T0	Participants 70 90	Parkinson's disease.
T1	Participants 165 189	Parkinson's Disease (PD)
T2	Participants 244 365	subjects randomized to either the STN (N = 14) or GPi (N = 14) who were assessed on a range of clinical balance measures.
T3	Participants 432 507	A control PD group was tested over the same period without surgery (N = 9).